A Safety and Efficacy Study of Obinutuzumab Alone or in Combination With Chemotherapy in Participants With Chronic Lymphocytic Leukemia
Clinical trial NCT01905943 · COMPLETED
Trial details
- NCT number
- NCT01905943
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-11-04
- Primary completion
- 2016-12-29
- Enrollment
- 979
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.